Bennett Weintraub

Insider Reports History

Location
Hopewell, NJ
Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bennett Weintraub:

Company Role Class Num Shares Value Price $ Report Date Ownership
Apimeds Pharmaceuticals US, Inc. Director Stock Option (right to buy) 10,000 11 Nov 2025 Direct

Insider Reports Filed by Bennett Weintraub

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APUS Apimeds Pharmaceuticals US, Inc. 11 Nov 2025 1 $0 4 Director 13 Nov 2025, 18:43
APUS Apimeds Pharmaceuticals US, Inc. 15 Oct 2025 1 $0 4 Director 17 Oct 2025, 19:10
APUS Apimeds Pharmaceuticals US, Inc. 16 May 2025 1 $0 4 Director 20 May 2025, 16:46
APUS Apimeds Pharmaceuticals US, Inc. 04 Mar 2025 0 $0 3 Director 08 May 2025, 17:24